BICO Group 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Maria Forss

최고 경영자

SEK 7.4m

총 보상

CEO 급여 비율	6.5%
CEO 임기	less than a year
CEO 소유권	0.06%
경영진 평균 재임 기간	1.7yrs
이사회 평균 재임 기간	4.1yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Maria Forss 의 보수는 BICO Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	-SEK 1b
Mar 31 2024	n/a	n/a	-SEK 2b
Dec 31 2023	SEK 7m	SEK 484k	-SEK 2b

보상 대 시장: Maria 의 총 보상 ($USD 674.13K ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 1.48M ).

보상과 수익: Maria 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Maria Forss (52 yo)

less than a year

테뉴어

SEK 7,425,520

보상

Ms. Maria Forss serves as President & CEO of BICO Group AB (publ) since November 20, 2023. She served as Senior Vice President of Consumables at Vitrolife AB (publ) since January 01, 2022 until August 2023...

리더십 팀

이름	위치	테뉴어	보상	소유권
Maria Forss	President & CEO	less than a year	SEK 7.43m	0.057% $ 137.1k
Jacob Thordenberg	Group Chief Financial Officer	1.8yrs	데이터 없음	0.026% $ 63.0k
Marius Balger	Chief Operating Officer	1.7yrs	데이터 없음	데이터 없음
Asa Hillsten	Senior VP & Head of Investor Relations	no data	데이터 없음	데이터 없음
Andreas Joersjo	General Counsel	less than a year	데이터 없음	데이터 없음
Artur Aira	Head of Corporate Development and M&A	1.7yrs	SEK 150.00k	데이터 없음
Catharina Nordlund	Global Head of Human Resources	less than a year	데이터 없음	데이터 없음
Itedale Redwan	Chief Scientific Officer - Bioprinting	no data	데이터 없음	데이터 없음
Niclas Emanuelsson	Head of Global Operations	4.8yrs	데이터 없음	데이터 없음
Holger Eickhoff	Senior VP & Business Area Director - Bioautomation	2.8yrs	데이터 없음	데이터 없음
Erica Bell	Senior VP & Chief People Officer	no data	데이터 없음	데이터 없음
Nicolas Gabriel-Robez	Chief Security Officer	no data	데이터 없음	데이터 없음

1.7yrs

평균 재임 기간

51.5yo

평균 연령

경험이 풍부한 관리: CLLK.F 의 관리팀은 경험 (평균 재직 기간 1.7 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Rolf Classon	Independent Chairman of the Board	2.6yrs	SEK 650.00k	0.044% $ 106.1k
Christian Wildmoser	Independent Director	4.9yrs	SEK 285.00k	0.45% $ 1.1m
Robert Langer	Member of Scientific Advisory Board	4yrs	데이터 없음	데이터 없음
Helena Skantorp	Independent Director	4.9yrs	SEK 350.00k	0.0057% $ 13.7k
Ulrika Dellby	Independent Deputy Chairwoman	2.6yrs	SEK 510.00k	0.027% $ 65.0k
Bengt Sjoholm	Independent Director	8.8yrs	SEK 285.00k	0.49% $ 1.2m
Susan Tousi	Independent Director	3yrs	SEK 250.00k	데이터 없음
Ali Khademhosseini	Member of Scientific Advisory Board	7.7yrs	데이터 없음	데이터 없음
Ido Amit	Member of Scientific Advisory Board	4.3yrs	데이터 없음	데이터 없음
Alexandra Gatzemeyer	Director	less than a year	데이터 없음	데이터 없음

4.1yrs

평균 재임 기간

66.5yo

평균 연령

경험이 풍부한 이사회: CLLK.F 의 이사회는 경험(평균 재직 기간 4.1 년)으로 간주됩니다.

BICO Group 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

BICO Group AB (publ), Annual General Meeting, May 08, 2025

BICO Group AB Announces Management Changes

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

Recent updates

BICO Group AB (publ) to Report Fiscal Year 2024 Final Results on Mar 20, 2025

BICO Group AB (publ), Annual General Meeting, May 08, 2025

BICO Group AB Announces Management Changes

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

BICO (publ) Appoints Mikael Engblom as Interim CFO

BICO Group AB (Publ) Announces Board Appointments

BICO Reaches Beneficial and Sustainable Solution with Organovo

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CELLINK Receives Patent for Robotic Systems for Personalized and Automated Aesthetic Medical Procedures

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Discover Echo Inc.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Nanoscribe GmbH for approximately €37 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Nanoscribe GmbH for €34 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire MatTek Corporation for $68 million.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Ginolis Ltd from Verso Fund II of Verso Capital Oy, Finnvera plc and Innovestor Ventures for €65.7 million.

Cellink AB (publ) to Report Fiscal Year 2021 Results on Mar 16, 2022

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Ginolis Ltd for €70 million.

Cellink AB (publ) Announces Distribution Agreement Including New Products for Single-Cell RNA Sequencing and NGS Library Preparation

Cellink Announces Third Year Extension of Collaboration with A Global Biopharmaceutical Company for Drug Discovery

Cellink and Phasefocus Announces a Partnership to Bring Livecyte High Content Live Cell Imager to a Wider Audience

Cellink AB (publ) Elects Aristotelis Nastos as Member of the Board of Directors

CELLINK and Atelerix Team Up to Enable the Shipping At Room Temperature of Fragile 3D Bioprinted Constructs by the World's Bioprinting Community

CELLINK to Help Develop 3D Bioprinted Personalised Scaffolds for Tissue Regeneration of Ankle Joint S as Part of the Triankle Project

Cellink AB (publ) to Report Second Half, 2020 Results on Oct 22, 2020

Cellink AB (Publ) Announces Leaving Board of Directors for an Operational Role as Business Area Manager for the Bioprinting Business Unit

Cellink AB (publ) (OM:CLNK B) completed the acquisition of SCIENION AG from NRW.Bank Venture Fonds, L.P., managed by NRW.Bank, Investment Arm and other shareholders.

Cellink AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 945.99632 million.

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령